These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 33677950)

  • 21. Application of the DETECT algorithm for detection of risk of pulmonary arterial hypertension in systemic sclerosis: data from a Czech tertiary centre.
    Soukup T; Pudil R; Kubinova K; Hromadkova L; Dusek J; Tosovsky M; Bradna P; Hrncir Z; Bures J
    Rheumatology (Oxford); 2016 Jan; 55(1):109-14. PubMed ID: 26320140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study.
    Thakkar V; Stevens W; Prior D; Youssef P; Liew D; Gabbay E; Roddy J; Walker JG; Zochling J; Sahhar J; Nash P; Lester S; Rischmueller M; Proudman SM; Nikpour M
    Arthritis Res Ther; 2013; 15(6):R193. PubMed ID: 24246100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haemodynamic effects of PAH-targeted therapies in pulmonary hypertension due to lung disease: A systematic review and meta-analysis.
    Farmakis IT; Vazakidis P; Doundoulakis I; Arvanitaki A; Zafeiropoulos S; Boutou A; Karvounis H; Giannakoulas G
    Pulm Pharmacol Ther; 2021 Jun; 68():102036. PubMed ID: 33979684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis.
    Hao Y; Thakkar V; Stevens W; Morrisroe K; Prior D; Rabusa C; Youssef P; Gabbay E; Roddy J; Walker J; Zochling J; Sahhar J; Nash P; Lester S; Rischmueller M; Proudman SM; Nikpour M
    Arthritis Res Ther; 2015 Jan; 17(1):7. PubMed ID: 25596924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival.
    Humbert M; Yaici A; de Groote P; Montani D; Sitbon O; Launay D; Gressin V; Guillevin L; Clerson P; Simonneau G; Hachulla E
    Arthritis Rheum; 2011 Nov; 63(11):3522-30. PubMed ID: 21769843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of the revised haemodynamic definition on the diagnosis of pulmonary hypertension in patients with systemic sclerosis.
    Jaafar S; Visovatti S; Young A; Huang S; Cronin P; Vummidi D; McLaughlin V; Khanna D
    Eur Respir J; 2019 Aug; 54(2):. PubMed ID: 31196948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.
    Coghlan JG; Denton CP; Grünig E; Bonderman D; Distler O; Khanna D; Müller-Ladner U; Pope JE; Vonk MC; Doelberg M; Chadha-Boreham H; Heinzl H; Rosenberg DM; McLaughlin VV; Seibold JR;
    Ann Rheum Dis; 2014 Jul; 73(7):1340-9. PubMed ID: 23687283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance of the DETECT Algorithm for Pulmonary Hypertension Screening in a Systemic Sclerosis Cohort.
    Young A; Moles VM; Jaafar S; Visovatti S; Huang S; Vummidi D; Nagaraja V; McLaughlin V; Khanna D
    Arthritis Rheumatol; 2021 Sep; 73(9):1731-1737. PubMed ID: 33760392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The clinical characteristics of systemic sclerosis-related pulmonary arterial hypertension].
    Wang H; Tian Z; Liu Y; Li M; Wang Q; Zeng X; Fang Q
    Zhonghua Nei Ke Za Zhi; 2014 May; 53(5):390-3. PubMed ID: 25146407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary arterial hypertension associated with systemic sclerosis in the Czech Republic.
    Jansa P; Becvar R; Ambroz D; Palecek T; Tomcik M; Skacelova S; Aschermann M; Linhart A
    Clin Rheumatol; 2012 Mar; 31(3):557-61. PubMed ID: 22105781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Impact of bosentan therapy on stress-induced pulmonary hypertension in patients with systemic sclerosis].
    Volkov AV; Kurmukov IA; Yudkina NN; Glukhova SI; Nikolaeva EV
    Ter Arkh; 2015; 87(1):49-56. PubMed ID: 25823269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update in systemic sclerosis-associated pulmonary arterial hypertension.
    Gashouta MA; Humbert M; Hassoun PM
    Presse Med; 2014 Oct; 43(10 Pt 2):e293-304. PubMed ID: 25179278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The spectrum of systemic sclerosis-associated pulmonary hypertension: Insights from the ASPIRE registry.
    Smith H; Thompson AAR; Akil M; Alabed S; Charalampopoulos A; Dwivedi K; Elliot CA; Hameed A; Haque A; Hamilton N; Hill C; Hurdman J; Kilding R; Kuet KP; Rajaram S; Rothman AMK; Swift AJ; Wild JM; Kiely DG; Condliffe R
    J Heart Lung Transplant; 2024 Oct; 43(10):1629-1639. PubMed ID: 39260921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospects for improving outcomes in systemic sclerosis-related pulmonary hypertension.
    Thakkar V; Nikpour M; Stevens WM; Proudman SM
    Intern Med J; 2015 Mar; 45(3):248-54. PubMed ID: 25735576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarkers of haemodynamic severity of systemic sclerosis-associated pulmonary arterial hypertension by serum proteome analysis.
    Sanges S; Rice L; Tu L; Valenzi E; Cracowski JL; Montani D; Mantero JC; Ternynck C; Marot G; Bujor AM; Hachulla E; Launay D; Humbert M; Guignabert C; Lafyatis R
    Ann Rheum Dis; 2023 Mar; 82(3):365-373. PubMed ID: 36600187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
    Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
    [No Abstract]   [Full Text] [Related]  

  • 37. Screening for pulmonary arterial hypertension in systemic sclerosis: A systematic literature review.
    Bruni C; De Luca G; Lazzaroni MG; Zanatta E; Lepri G; Airò P; Dagna L; Doria A; Matucci-Cerinic M
    Eur J Intern Med; 2020 Aug; 78():17-25. PubMed ID: 32540411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral Microangiopathy Changes in Pulmonary Arterial Hypertension Related to Systemic Sclerosis: Data From a Multicenter Observational Study.
    Giuggioli D; Riccieri V; Cipolletta E; Del Papa N; Ingegnoli F; Spinella A; Pellegrino G; Risa AM; de Pinto M; Papa S; Armentaro G; De Angelis R
    Front Cardiovasc Med; 2022; 9():924899. PubMed ID: 35898279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determining the necessity for right heart catheterization in pulmonary hypertension associated with connective tissue diseases assessed by echocardiography.
    Choi JH; Joo SJ; Kim J
    Int J Rheum Dis; 2016 Jan; 19(1):65-73. PubMed ID: 26820839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary Hypertension in Scleroderma- Evaluation and Management.
    Chennakesavulu PV; Uppaluri S; Koyi J; Jhaveri S; Avanthika C; Sakhamuri LT; Ashokbhai PK; Singh P
    Dis Mon; 2023 Jul; 69(7):101468. PubMed ID: 36163292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.